Galderma Canada Inc. et al. v Sandoz Canada Inc.

Call to arrange a consultation

2020

T-886-20

Pending

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,440,472, 2,521,885, and 2,803,922 (doxycycline)

Counsel to:

Sandoz Canada Inc.

The decision is reported

Partner

Associate